Search

Tetrapeptide Compositions for Treating Eye Disorders

The USPTO granted patent US12605422B2 to S.I.S SHULOV INNOVATIVE SCIENCE LTD. on April 21, 2026, covering tetrapeptide pharmaceutical compositions for treating degenerative, age-related, and trauma-induced disorders of the eye. The patent, application number 17762984, was filed September 23, 2020, and contains 20 claims classified under CPC codes A61K 38/07, A61P 25/28, and C07K 5/1024.

NB Science M3 Mutant Peptide Patent for Myopathy, Obesity, Diabetes

USPTO granted patent US12605431B2 to NB SCIENCE CO., LTD. on April 21, 2026. The patent covers an M3 mutant peptide composition for treating or preventing myopathy, obesity, or diabetes, listing five claims under CPC classifications including A61K 38/4886 and A61P 3/04. The application (18267252) was filed on December 14, 2021.